TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 88 filers reported holding TRINITY BIOTECH PLC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $9,714,000 | -39.9% | 849,095 | -5.2% | 0.61% | -29.3% |
Q2 2015 | $16,170,000 | -8.4% | 895,368 | -2.3% | 0.86% | -11.8% |
Q1 2015 | $17,644,000 | +9.0% | 916,595 | -0.8% | 0.97% | +3.7% |
Q4 2014 | $16,181,000 | -7.1% | 924,072 | -3.1% | 0.94% | -13.1% |
Q3 2014 | $17,423,000 | -12.2% | 953,618 | +10.7% | 1.08% | +0.7% |
Q2 2014 | $19,843,000 | +29.7% | 861,625 | +36.5% | 1.07% | +33.8% |
Q1 2014 | $15,295,000 | +8.7% | 631,244 | +12.8% | 0.80% | +6.5% |
Q4 2013 | $14,066,000 | +175.5% | 559,525 | +138.5% | 0.75% | +138.7% |
Q3 2013 | $5,105,000 | +1756.4% | 234,610 | +1339.3% | 0.32% | +1752.9% |
Q2 2013 | $275,000 | – | 16,300 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
Centaur Capital | 77,500 | $887,000 | 1.33% |
Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
RK Capital | 565,472 | $6,469,000 | 1.18% |
Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |